These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36006515)

  • 21. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Parosmia and phantosmia: clinical update].
    Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
    Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An olfactory perceptual fingerprint in people with olfactory dysfunction due to COVID-19.
    Drnovsek E; Rommel M; Bierling AL; Croy A; Croy I; Hummel T
    Chem Senses; 2023 Jan; 48():. PubMed ID: 38098233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of COVID-19-Mediated Olfactory Loss on Quality of Life.
    Otte MS; Haehner A; Bork ML; Klussmann JP; Luers JC; Hummel T
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(1):1-6. PubMed ID: 35413715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperbaric oxygen therapy for treatment of COVID-19-related parosmia: a case report.
    Krimus L; Hasan Rizvi S; Marinov A; Clarke H; Katznelson R
    Undersea Hyperb Med; 2023; 50(4):433-435. PubMed ID: 38055885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Well-being in patients with olfactory dysfunction.
    Mai Y; Menzel S; Cuevas M; Haehner A; Hummel T
    Physiol Behav; 2022 Oct; 254():113899. PubMed ID: 35809697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical factors associated with lower health scores in COVID-19-related persistent olfactory dysfunction.
    Said M; Luong T; Jang SS; Davis ME; DeConde AS; Yan CH
    Int Forum Allergy Rhinol; 2022 Oct; 12(10):1242-1253. PubMed ID: 35032409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-3 supplementation in postviral olfactory dysfunction: a pilot study.
    Hernandez AK; Woosch D; Haehner A; Hummel T
    Rhinology; 2022 Apr; 60(2):139-144. PubMed ID: 35112672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The applicability of the "Sniffin' Sticks" olfactory test in a Turkish population.
    Tekeli H; Altundağ A; Salihoğlu M; Cayönü M; Kendirli MT
    Med Sci Monit; 2013 Dec; 19():1221-6. PubMed ID: 24382345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.
    Le Bon SD; Pisarski N; Verbeke J; Prunier L; Cavelier G; Thill MP; Rodriguez A; Dequanter D; Lechien JR; Le Bon O; Hummel T; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):101-108. PubMed ID: 32754871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19 related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    medRxiv; 2022 Nov; ():. PubMed ID: 35350197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Features of Parosmia Associated With COVID-19 Infection.
    Lerner DK; Garvey KL; Arrighi-Allisan AE; Filimonov A; Filip P; Shah J; Tweel B; Del Signore A; Schaberg M; Colley P; Govindaraj S; Iloreta AM
    Laryngoscope; 2022 Mar; 132(3):633-639. PubMed ID: 34870334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of Retronasal Olfactory Threshold Values.
    Özay H; Çetin AÇ; Ecevit MC
    Laryngoscope; 2021 Jul; 131(7):1608-1614. PubMed ID: 33533495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osmophobia and olfactory functions in patients with migraine.
    Kayabaşoglu G; Altundag A; Kotan D; Dizdar D; Kaymaz R
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):817-821. PubMed ID: 27577041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation study of the "Sniffin' Sticks" olfactory test in a British population: a preliminary communication.
    Neumann C; Tsioulos K; Merkonidis C; Salam M; Clark A; Philpott C
    Clin Otolaryngol; 2012 Feb; 37(1):23-7. PubMed ID: 22433135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with parosmia respond faster to unpleasant odors than patients with hyposmia: Insights from olfactory event-related potentials.
    Li Z; Richter L; Krueger T; Eichwald H; Hähner A; Hummel T
    Int Forum Allergy Rhinol; 2024 Sep; 14(9):1446-1454. PubMed ID: 38584570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Euosmia: a rare form of parosmia.
    Landis BN; Frasnelli J; Hummel T
    Acta Otolaryngol; 2006 Jan; 126(1):101-3. PubMed ID: 16308262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical application of Sniffin' Sticks olfactory psychophysical measurements].
    Yang L; Wei YX; Ren YY; Yu D; Sun YX; Yang BB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Sep; 48(9):741-5. PubMed ID: 24330876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Subjective and objectified smell and taste disorders from an ENT post-Covid-19 consultation].
    Gudziol H; Bitter T; Schade U; Laute K; Guntinas-Lichius O
    Laryngorhinootologie; 2023 Dec; 102(12):933-943. PubMed ID: 37339661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.